Peter S Sever

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial— Lipid Lowering Arm (ASCOT-LLA): A Multicentre Randomised Controlled Trial

R. Collins, M. Caulfield, S. Kjeldsen, 2003, The Lancet.

Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT‐BPLA: comparison of their relative predictability using a novel approach

N. Poulter, P. Sever, D. Prieto-Merino, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial

C. Ariti, T. Godec, Ajay K. Gupta, 2024, European heart journal.